CRL Q1 2026 Earnings Strong EPS Beat Drives Positive Stock Reaction Envoy Medical Q1 2026 Earnings EPS Surprises to the Upside Despite No Revenue Stock Declines ARQT Q1 2026 Earnings EPS Miss Amid Biotech Sector Headwinds ICE Q1 2026 Earnings Earnings Beat Estimates on 29 Surprise Shares Edge Higher Processa Pharmaceuticals PCSA Q4 2025 Earnings EPS Misses Estimates by a Wide Margin as PreRevenue Biotech Advances Pipeline ASND Q1 2026 Earnings Wide EPS Miss as Ascendis Pharma Remains PreRevenue Stock Edges Higher